News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Biogemma extends SRS partnership

.

Cambridge, United Kingdom
October 14, 2008

BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that Biogemma has renewed its SRS licenses for a further three year term. .

SRS is the world’s leading bioinformatics data integration platform, designed to meet the database search and retrieval needs of both Biologists and Bioinformaticians alike.

“We are delighted that Biogemma continue to gain value from our SRS platform and we look forward to working closely with them over the next three years.” said Chris Hodkinson, Chief Operating Officer at BioWisdom. “SRS provides a unique system for data integration that is in daily use by over 30,000 people worldwide”

“The rapid growth and development of cutting-edge DNA sequencing technologies strengthen crops research and oversize data volume. SRS offer a robust way to gather sequences and related information, with lot of functions supporting data integrations and querying.” said Olivier Dugas, Upstream Genomics Coordinator at Biogemma.
“WebServices provided by SRS allowed us to build our modular Bioinformatics environment, which we now share in the frame of our collaborations with Crops research companies”.

BioWisdom delivers intelligence for the Healthcare Industry and helps clients to navigate the complex scientific and commercial issues involved in developing successful healthcare products. The company provides a powerful suite of software tools for the formatting, search, visualization and high value analysis of healthcare intelligence. The BioWisdom team combines extensive experience of the pharmaceutical and biotechnology industries with proven expertise in life science software development.
For more information, please visit 

Biogemma is a leading biotech company in Europe involved in Genomics applied to Field crops. Resulting from the merger of the biotech activity of three major seed business companies in France, and with the help of two financial institutions, the company is developing R&D programs with its partners, mainly in corn, wheat, rapeseed and sunflower, focused on biotic and abiotic stresses and specialty grain compounds.

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved